GlassScriptPhysician profile
Phillip Lorane Robinson
NPI 1366424392
$5,088.31
in general payments reported to CMS, 2019-2025
13 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,601 · 2020: $532 · 2021: $172 · 2022: $1,004 · 2023: $658 · 2024: $20.00 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $759 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $759.14 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,019.32 | 2019-2023 | |
| Atricure, INC. | $1,307.93 | 2019-2023 | |
| Abbott Laboratories | $848.62 | 2019-2022 | |
| Corcym INC | $300.56 | 2022-2023 | Perceval |
| Medtronic, INC. | $267.63 | 2022 | |
| Getinge USA Sales, LLC | $100.92 | 2021-2025 | Vasoview Hemopro 2 |
| Lsi Solutions INC | $62.50 | 2022 | |
| Medtronic Vascular, INC. | $57.63 | 2020 | |
| Ethicon US, LLC | $32.82 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.57 | 2025 | Lifevest |
| Hemosonics LLC | $23.62 | 2023 | Quantra Qplus System |
| Becton, Dickinson and Company | $21.19 | 2019 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.